Onconetix, Inc. (ONCO)
NASDAQ: ONCO · Real-Time Price · USD
1.080
-0.010 (-0.92%)
At close: Jun 16, 2026, 4:00 PM EDT
1.260
+0.180 (16.67%)
After-hours: Jun 16, 2026, 7:59 PM EDT
Onconetix Market Cap
Onconetix has a market cap or net worth of $1.24 million as of June 16, 2026. Its market cap has decreased by -65.11% in one year.
Market Cap
1.24M
Enterprise Value
-2.19M
1-Year Change
-65.11%
Ranking
Category
Stock Price
$1.08
Market Cap Chart
Since the IPO on February 18, 2022, Onconetix's market cap has decreased from $624.51M to $1.24M, a decrease of -99.80%. That is a compound annual growth rate of -76.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 16, 2026 | 1.24M | -48.96% |
| Dec 31, 2025 | 2.43M | -53.56% |
| Dec 31, 2024 | 5.22M | 43.70% |
| Dec 29, 2023 | 3.64M | -78.64% |
| Dec 30, 2022 | 17.02M | -97.28% |
| Feb 18, 2022 | 624.51M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Oragenics | 2.76M |
| Ensysce Biosciences | 2.58M |
| Bone Biologics | 2.48M |
| Calidi Biotherapeutics | 2.45M |
| Biodexa Pharmaceuticals | 2.22M |
| Valion Bio | 1.76M |
| Propanc Biopharma | 1.61M |
| Jaguar Health | 1.39M |